Lv41
780 积分 2024-02-19 加入
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
14天前
已完结
The Role of IL-12 Family Cytokines in the Pathogenesis of Periodontal Disease: A Therapeutic Approach
27天前
已完结
Interleukin‐25 promotes basic fibroblast growth factor expression by human endothelial cells through interaction with IL‐17RB, but not IL‐17RA
28天前
已完结
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
29天前
已完结
The role of IL-6 in host defence against infections: immunobiology and clinical implications
29天前
已完结
Asthma Phenotypes as a Guide for Current and Future Biologic Therapies
1个月前
已完结
SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
1个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
1个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3)：a multinational，multicentre，non-inferiority，open-label，randomised，phase 3 trial
1个月前
已关闭
SIM0708, an antibody-drug conjugate (ADC) with half-life extended anti-IL-4 receptor a (IL-4Ra) antibody and glucocorticoid receptor modulator exhibits superior efficacy treating inflammatory diseases 4657
1个月前
已完结
皖公网安备34019202002308
